Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan Ni

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncology Letters|December 6, 2021
RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cellsJing Ke, Kan Ni, Huimin Xue, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Path Following for Autonomous Mobile Robots with Deep Reinforcement LearningYu Cao, Kan Ni, Takahiro Kawaguchi, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
Clinical Characteristics and Prognosis of Breast Signet Ring Cell Carcinoma: A Propensity Score-Matched, Population-Based StudyYan Li, Kan Ni, Changjiang Gu, et al.
Translational Cancer Research|May 25, 2026
Network pharmacology approach and experimental verification of Danzhi Xiaoyao Powder for breast cancer treatment based on UHPLC-Q-Orbitrap HRMSKan Ni, Nan Xu, Xun Lu, et al.
Human Pathology|November 7, 2017
High TREM2 expression correlates with poor prognosis in gastric cancerXiaojing Zhang, Wei Wang, Peng Li, et al.
Computational and Mathematical Methods in Medicine|September 26, 2022
Comparison of Efficacy and Psychology of Breast-Conserving Surgery and Modified Radical Mastectomy on Patients with Early Breast Cancer under Graded NursingTiantian Ren, Jianli Wu, Lu Qian, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 26, 2018
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2Peng Ma, Kan Ni, Jing Ke, et al.
Frontiers in Oncology|June 28, 2021
The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression <i>via</i> Controlling the TGF-β Signaling PathwayKan Ni, Zhiqi Huang, Yichun Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2025
Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9Yelan Tang, Kan Ni, Kangfeng Jin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 17, 2013
Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter GourdTing-Ni Huang, Kan-Ni Lu, Yi-Ping Pai, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncology Letters|December 6, 2021
RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cellsJing Ke, Kan Ni, Huimin Xue, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Path Following for Autonomous Mobile Robots with Deep Reinforcement LearningYu Cao, Kan Ni, Takahiro Kawaguchi, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 24, 2025
Clinical Characteristics and Prognosis of Breast Signet Ring Cell Carcinoma: A Propensity Score-Matched, Population-Based StudyYan Li, Kan Ni, Changjiang Gu, et al.
Translational Cancer Research|May 25, 2026
Network pharmacology approach and experimental verification of Danzhi Xiaoyao Powder for breast cancer treatment based on UHPLC-Q-Orbitrap HRMSKan Ni, Nan Xu, Xun Lu, et al.
Human Pathology|November 7, 2017
High TREM2 expression correlates with poor prognosis in gastric cancerXiaojing Zhang, Wei Wang, Peng Li, et al.
Computational and Mathematical Methods in Medicine|September 26, 2022
Comparison of Efficacy and Psychology of Breast-Conserving Surgery and Modified Radical Mastectomy on Patients with Early Breast Cancer under Graded NursingTiantian Ren, Jianli Wu, Lu Qian, et al.
Experimental Biology and Medicine (Maywood, N.J.)|January 26, 2018
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2Peng Ma, Kan Ni, Jing Ke, et al.
Frontiers in Oncology|June 28, 2021
The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression <i>via</i> Controlling the TGF-β Signaling PathwayKan Ni, Zhiqi Huang, Yichun Zhu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 24, 2025
Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9Yelan Tang, Kan Ni, Kangfeng Jin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 17, 2013
Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter GourdTing-Ni Huang, Kan-Ni Lu, Yi-Ping Pai, et al.
Pageof 2